CDNA vs NEOG
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 17, 2026
CDNA
NEOG
Investment Advisor Scores
NEOG
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CDNA | NEOG | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 151.5152 | 16 | NEOG |
| PEG Ratio | -0.12 | 0.6575 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 52.2% | -0.1% | CDNA |
| Earnings Growth | 0.0% | -85.6% | CDNA |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 32.9/100 | 41.0/100 | NEOG |
| Profit Margin | 24.2% | -0.9% | CDNA |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | EXTENDED | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CDNA
MarkupPrice above SMA50, rising 50-day trend (24.8% over 20 days), RSI 81
NEOG
NeutralMixed signals - no dominant trend phase, RSI 48
Fundamentals Snapshot
| Metric | CDNA | NEOG |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 51.3 | 40.8 |
| Trailing P/E | 30.8 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.5% | 0.0% |
| Gross Margin | 0.7% | 0.5% |
| Operating Margin | 0.0% | 0.0% |
| EPS | 2.11 | -0.04 |
| Dividend Yield | — | — |